INMOLECULE

Research INMOLECULE (MLINA.PA) on Bullrun: market cap EUR 29.85M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 29.85M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024EUR 1.98M-EUR 227.74Kn/a79.9%n/aEUR 87.30KEUR 1.94MEUR 7.39M
FY2023EUR 1.53M-EUR 1.63Mn/a53.8%-0.22EUR 59.61KEUR 2.62MEUR 8.54M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-11EUR 29.85Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About INMOLECULE

INMOLECULE NANOTECH, S.A., a biotech company, develops active ingredient nano particles for various applications in the home and personal care, agriculture, aquaculture, and pharmaceutical industries. The company provides Nano-Phyto-Chemistry platform that utilizes plant extracts at the nanometric scale to eliminate infectious germs, including viruses, fungi, bacteria, spores, and mycobacteria, and others. Its products include surface sanitizers/disinfectants, and vitamin C and zinc dietary supplements.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is INMOLECULE's market cap?

INMOLECULE's market capitalization is EUR 29.85M.

What does INMOLECULE do?

INMOLECULE NANOTECH, S.A., a biotech company, develops active ingredient nano particles for various applications in the home and personal care, agriculture, aquaculture, and pharmaceutical industries. The company provides Nano-Phyto-Chemistry platform that utilizes plant extracts at the nanometric scale to eliminate infectious germs, including viruses, fungi, bacteria, spores, and mycobacteria, and others. Its products include surface sanitizers/disinfectants, and vitamin C and zinc dietary supplements. The company was founded in 1999 and is based in Madrid, Spain.